Oman Investment Authority invests in U.S. neurotechnology company Neuralink
6 May 2026
Oman Investment Authority (OIA) invested in U.S.-based Neuralink, a neurotechnology company developing brain-computer interfaces with potential healthcare applications.
The investment expands OIA’s international technology portfolio and provides exposure to a high-growth field at the intersection of neuroscience, medical devices and artificial intelligence.
Read the original article: Oman News Agency
